Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600117649Phase 4Not yet recruiting
Phase 4, randomised trial of dexamethasone and edaravone in not applicable; "lung injury" is not a specific disease (4 arms), sponsored by The Second Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: Postoperative pulmonary complications within 7 days. Planned start Jan 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600117649.